Results 121 to 130 of about 28,611,700 (297)
Final Deliverable W6, D6.4: Coal power plants with carbon capture and storage – A sustainability assessment [PDF]
Carbon Capture and Storage (CCS) is increasingly gaining attention as a strategy for the abatement of greenhouse gas (GHG) emissions. CCS includes the capture of CO2 emissions from electricity generation plants and/or industrial processes, its transport (
Grytli, T. +5 more
core
RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease
ABSTRACT Objective Mitochondrial diseases are the most common inherited metabolic disorders, characterized by pronounced clinical and genetic heterogeneity that complicates molecular diagnosis. Although DNA‐based sequencing approaches have become standard in genetic testing, up to half of patients remain without a definitive diagnosis.
Zhimei Liu +21 more
wiley +1 more source
ABSTRACT Objective To assess the association and discriminative performance of serum biomarkers with clinical disease progression and survival in patients with amyotrophic lateral sclerosis (ALS). Methods This retrospective study, conducted at Houston Methodist Hospital, Houston, TX, used longitudinal serum samples collected between January 2018 and ...
David R. Beers +7 more
wiley +1 more source
Probing barrow entropy models with future event horizon as IR cutoff
We develop formulations for barrow holographic dark energy (BHDE) in both non-interacting and interacting scenarios within a cosmological framework, applying the conventional holographic principle.
L. Sudharani, N.S. Kavya, V. Venkatesha
doaj +1 more source
Deployment pathways for decarbonising industry and electricity generation: System analysis of the techno-economic feasibility and implementation of CO2 capture and transport for different geographical scales [PDF]
The main objective of this thesis is to assess promising deployment pathways for CO2 capture and transport in industry and the electricity generation sector. To meet this objective, the following three research questions were formulated: I. What are cost
Energy System Analysis +2 more
core
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
This paper deals with a method called Statistical Energy Analysis that can be applied to the mechanical and acoustical systems like buildings, bridges and aircrafts etc. S.E.A as a tool can be applied to the resonant systems in the circumstances of high
Hawraa S. Ibraham, Adnan D. Mohammed
doaj +2 more sources
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
On the usefulness of entropy in statistical energy analysis
Statistical energy analysis is well-known method in the field of high frequencies. This method is founded on an analogy with thermodynamics and is largely inspired from results of statistical mechanics. But nowadays, the method is limited to the prediction of vibrational energies by application of the first principle of thermodynamics that is an energy
Le Bot, Alain +2 more
openaire +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source

